2016 annual financial data
NovoCure 2016 Operating margin
Direct answer
Operating margin was -139.12%.
Operating income was -115,317,000 USD and net income was -131,845,000 USD.
Operating cash flow was -107,592,000 USD.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 82,888,000 USD
- Operating income
- -115,317,000 USD
- Net income
- -131,845,000 USD
- Operating cash flow
- -107,592,000 USD